Research Library

Premenstrual spotting of ≥2 days is strongly associated with histologically confirmed endometriosis in women with infertility.

Heitmann RJ et al. Am J Obstet Gynecol. 2014.

​

Body weight and body composition of depot medroxyprogesterone acetate users.

Dal'Ava N et al. Contraception. 2014.

​

Cohort efficacy study of natural family planning among perimenopause age women.

Fehring RJ et al. J Obstet Gynecol Neonatal Nurs. 2014.

​

Inherited Thrombophilia.

Phillippe HM et al. J Pharm Pract. 2014.

​

Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.

Beaber EF et al. Cancer Epidemiol Biomarkers Prev. 2014.

​

Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

No Authors Listed. MMWR Recomm Rep. 2014.

​

Hormonal contraceptive use and breast cancer in Thai women.

Poosari A et al. J Epidemiol. 2014.

​

Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria.

Schliep KC et al. J Clin Endocrinol Metab. 2014.

​

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.

Holman LL et al. Gynecol Oncol. 2014.

​

Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.

Dinger J et al. Contraception. 2014.

​

The association between endometriosis and chronic endometritis.

Takebayashi A et al. PLoS One. 2014.

​

Variability in the morphologic assessment of human sperm: use of the strict criteria recommended by the World Health Organization in 2010.

Wang Y et al. Fertil Steril. 2014.

​

Combination contraceptives: effects on weight.

Gallo MF et al. Cochrane Database Syst Rev. 2014.

​

In vitro effects of coital lubricants and synthetic and natural oils on sperm motility.

Sandhu RS et al. Fertil Steril. 2014.

​

Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.

Thorbjarnardottir T et al. Acta Oncol. 2014.

​

Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women.

Prior JC et al. PLoS One. 2014.

​

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.

Kotsopoulos J et al. Breast Cancer Res Treat. 2014.

​

Pilot test and validation of the peak day method of prospective determination of ovulation against a handheld urine hormone monitor.

Porucznik CA et al. BMC Womens Health. 2014.

​

Ethical dilemmas of hormonal contraception: Natural law and virtue ethics.

Laurinec J. 2014.

​

Ethical Issues in Hormonal Contraception: Natural Law and Virtue Ethics.

Laurinec J. 2014.

​

Trends in fertility treatments and outcomes in 2014.

HFEA. 2014.

​

Reproductive factors and breast cancer: a case-control study in tertiary care hospital of North India.

Bhadoria AS et al. Indian J Cancer. 2013.

​

The effect of oral contraceptive pills and the natural menstrual cYCLe on arterial stiffness and hemodynamICs (CYCLIC).

Yu A et al. J Hypertens. 2013.

​

Efficacy of achieving pregnancy with fertility-focused intercourse.

Mu Q et al. MCN Am J Matern Child Nurs. 2013.

​

Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian Multicentre Osteoporosis Study (CaMos).

Zhou W et al. J Musculoskelet Neuronal Interact. 2013.

​